Distance-delivered physical activity interventions for childhood cancer survivors: A systematic review and meta-analysis

2017 ◽  
Vol 118 ◽  
pp. 27-41 ◽  
Author(s):  
David Mizrahi ◽  
Claire E. Wakefield ◽  
Joanna E. Fardell ◽  
Veronica F. Quinn ◽  
Qishan Lim ◽  
...  
Cancers ◽  
2021 ◽  
Vol 13 (24) ◽  
pp. 6331
Author(s):  
Marco Torella ◽  
Gaetano Riemma ◽  
Pasquale De Franciscis ◽  
Marco La Verde ◽  
Nicola Colacurci

Background: Female childhood cancer survivors (CCS) might have impaired ovarian reserves, especially after alkylating agents or radiotherapy. The purpose of this systematic review and network meta-analysis is to evaluate the role of serum anti-Müllerian hormone (AMH) for ovarian reserve screening and the risk of premature ovarian insufficiency (POI) according to the subtype of childhood cancer. (2) Methods: PRISMA-NMA guidelines were followed. We carried out a network meta-analysis based on a random effects model for mixed multiple treatment comparisons to rank childhood cancers effects on fertility by surface under the cumulative ranking curve (SUCRA). Studies were selected only if they had an age-matched control group. Quality assessment was performed using Newcastle–Ottawa Scale. The co-primary outcomes were mean AMH levels and the incidence of POI. (3) Results: A total of 8 studies (1303 participants) were included. Women treated for a neuroblastoma during infancy were more likely to be ranked first for impaired AMH levels (SUCRA = 65.4%), followed by mixed CCS (SUCRA = 29.6%). The greatest rates of POI were found in neuroblastoma survivors (SUCRA = 42.5%), followed by acute lymphoid leukemia (SUCRA = 26.3%) or any other neoplasia (SUCR A= 20.5%). (4) Conclusions: AMH represents a trustworthy approach for ovarian reserve screening. Direct and indirect comparisons found no differences in mean AMH levels and POI risk between subtypes of CCS and healthy controls. SUCRA analysis showed that female neuroblastoma survivors were more at risk for reduced serum AMH levels and increased risk of POI.


2021 ◽  
Author(s):  
Tove Berg ◽  
Jens Böhmer ◽  
Bright Nwaru ◽  
Kristjan Karason ◽  
Marianne Jarfelt

Abstract BackgroundOver the past decades, survival rate for childhood cancer has greatly improved. However, the risk of late cardiac complications after such treatment remains high. Previous studies have shown that the risk for heart failure among childhood cancer survivors is significantly higher than that observed in the general population. The aim of this systematic review is to identify, critically appraise and synthesize existing population-based studies reporting on the frequency of heart failure, both incidence or prevalence, that may develop after treatment of childhood cancer.Method:The following databases will be searched from their inception date until May 17th 2021: Medline, Embase, Scopus, CINAHL, CAB International, AMED, Global Health, Psycinfo, Web of science and Google Scholar. Population-based studies reporting on the incidence and/or prevalence of heart failure after treatment of any type of childhood cancer will be included. Screening of articles, data extraction and quality assessment will be performed independently by two reviewers. The quality and risk of bias in the studies included will be assessed by using the Effective Public Health Practice Project tool. A narrative synthesis of the extracted data will be undertaken and, for studies that are sufficiently homogenous, a meta-analysis using random-effects models performed.DiscussionThis systematic review will provide a clearer picture of the epidemiology of heart failure after treatment of childhood cancer. Collected data will be of value for future childhood cancer treatment protocols and also offer guidance for post-treatment cardiac surveillance among survivors.Systematic review registrationThis protocol follows the structure of the recommendation of the preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) and has been submitted in PROSPERO on April 28th 2021, awaiting assignment of registration number.


2019 ◽  
Vol 142 ◽  
pp. 94-118 ◽  
Author(s):  
Javier S. Morales ◽  
Pedro L. Valenzuela ◽  
Cecilia Rincón-Castanedo ◽  
Alejandro Santos-Lozano ◽  
Carmen Fiuza-Luces ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document